4729-37-02 List of drugs to be reported.

 

 

 

Acting under the authority of the Ohio Revised Code Sections 119.03 to 119.13, 3715.69, 3719.28, 3719.44 and 4729.26, the State Board of Pharmacy hereby announces a public hearing will be held on Tuesday, April 8, 2014 at 10:00 a.m. in Room South A, 31st Floor, Vern Riffe Center for Government and the Arts, 77 South High Street, Columbus, Ohio.

 

This is a statement of the agency's intention to amend the following rules:

 

·          4729-3-03: Removes the requirement that a pharmacy intern submit an original transcript when  applying for a license.

 

·          4729-5-01: Permits the use of protocols for administration of vitamin K for prevention of Vitamin K  deficient bleeding in newborns and administration of erythromycin for the prevention of ophthalmia  neonatorum. The rule also removes the specific requirement that a thumbprint reader must be used to  provide positive identification. Instead, the rule allows for a number of different biometric  identification methods.

 

·          4729-5-38: Removes the requirement that an individual obtain a prescription prior to the  administration of the zoster (shingles) vaccine by a pharmacist.  This rule would still require that all  pharmacists check to ensure that the patient meets the age criteria specified in the F.D.A. approved  labeling for the vaccine and that the pharmacist has met the training approved by the rule in another  section of the code.

 

·          4729-5-15: Corrects a reference to the Ohio Revised Code in this section of the Ohio Administrative  Code that authorizes prescribers to write prescriptions.

 

·          4729-5-17: Amends the section to correspond with recent changes to Ohio Revised Code 4729.291  that limits personally furnishing controlled substances to a seventy-two hour supply and, in any thirty- day period, personally furnishing quantities supplied to all patients not to exceed two thousand five  hundred dosage units.

 

·          4729-5-21: Removes the requirement that pharmacies that receive electronic prescriptions file a serial hardcopy prescription in the prescription file.

 

·          4729-5-24: Amends this section to allow the board of pharmacy the ability to approve the transfer of a  copy of a prescription that does not meet the requirements provided in this section of rule.

 

·          4729-7-02: Changes the submission date for pharmacist continuing education requirements from  March 1st to September 15th.

 

·          4729-7-03: Removes the requirement that a pharmacist submit original continuing education  documentation.

 

·          4729-9-02: Removes the requirement that all pharmacies possess a paper copy of the references  necessary to conduct the practice of pharmacy. The regulation would require the pharmacy to either  have a paper copy or ensure access to the appropriate references via electronic means.

 

 

 

 

 

·          4729-10-01: Makes a technical correction to correspond with an updated section of the Ohio Revised  Code.

·          4729-15-05: Corrects a spelling error in a section of code that prohibits certain activities when working  with  radiopharmaceuticals.

·          4729-29-07: Removes the requirement that long-term-care facilities submit consult agreements to the  Board of Pharmacy prior to implementation. ORC 4729.39 authorizes a pharmacist practicing under a  consult agreement with a physician to manage an individual's drug therapy under specified conditions.

·          4729-31-04: Updates the rule to reflect current technology by removing references to outdated  equipment in rules relating to fluid therapy pharmacies.

·          4729-33-03: Updates the rule for the storage of dangerous drugs by an emergency medical service  organization to reflect changes in terminology adopted by the Ohio Department of Public Safety  regarding advanced emergency medical technicians (formally known as emergency medical technician -  intermediate).

·          4729-37-02: Removes redundant language requiring the reporting of carisoprodol to the Ohio  Automated Rx Reporting System (OARRS), as it has recently been classified by the DEA as a schedule IV  controlled substance.

·          4729-37-04: Requires pharmacies to report Pharmacy National Provider Information number and  Prescriber's National Provider Identification number to OARRS. The National Provider Identification  number is a standard number that all prescribers and pharmacies will have.

·          4729-37-07: Requires daily reporting of controlled substances and tramadol dispensed by pharmacies  and prescribers to the Ohio Automated Rx Reporting System (OARRS).

·          4729-37-11: Removes the requirement that correction to the OARRS system be made in writing and  allows for electronic corrections to the system.

The full text of the proposed rules are available at the office of the State Board of Pharmacy in printed form without charge to any person affected by such proposals. The proposed rules are also on the Board's website at http://pharmacy.ohio.gov/LawsRules/ProposedRules.aspx and on the Register of Ohio website at  www.registerofohio.state.oh.us.

On the date and at the time and place designated in this notice, any person affected by the proposed action of the State Board of Pharmacy may appear and be heard in person, by his/her attorney, or both; may present his/her position, arguments, or contentions orally or in writing; offer witnesses; and, present evidence tending to show that any proposal, if adopted or effectuated, will be unreasonable or unlawful.

Kyle W. Parker, M.B.A., R.Ph., Executive Director